Search Results

A2E Selectively Induces COX-2 in ARPE-19 and Human Neural Cells

Authors: Lukiw, Walter; Mukherjee, Pranab; Cui, Jian-Guo; Bazan, Nicolas

Source: Current Eye Research, Volume 31, Number 3, March 2006 , pp. 259-263(5)

Publisher: Informa Healthcare

Cloning of cyclooxygenase-1b (putative COX-3) in mouse

Authors: Kis, B.; Snipes, J.; Gaspar, T.; Lenzser, G.; Tulbert, C.; Busija, D.

Source: Inflammation Research, Volume 55, Number 7, July 2006 , pp. 274-278(5)

Publisher: Springer

In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells

Authors: WOLFESBERGER, B.; HOELZL, C.; WALTER, I.; REIDER, G. A.; FERTL, G.; THALHAMMER, J. G.; SKALICKY, M.; EGERBACHER, M.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 29, Number 1, February 2006 , pp. 15-23(9)

Publisher: Blackwell Publishing

Gastrointestinal perforation in five dogs associated with the administration of meloxicam

Authors: Enberg, Trevor B.; Braun, Laurence D.; Kuzma, Alan B.

Source: Journal of Veterinary Emergency and Critical Care, Volume 16, Number 1, March 2006 , pp. 34-43(10)

Publisher: Blackwell Publishing

Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?

Authors: Hersh, Elliot V.; Lally, Edward T.; Moore, Paul A.

Source: Current Medical Research and Opinion, Volume 21, Number 8, August 2005 , pp. 1217-1226(10)

Publisher: Informa Healthcare

Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2

Authors: W. Kiefer; G. Dannhardt

Source: Current Medicinal Chemistry, Volume 11, Number 24, December 2004 , pp. 3147-3161(15)

Publisher: Bentham Science Publishers

Cyclooxygenase-3 Gene Expression in Alzheimer Hippocampus and in Stressed Human Neural Cells

Authors: Jian-Guo Cui; Hitoshi Kuroda; N. Vishvanath Chandrasekharan; Ricardo Palacios Pelaez; Daniel L. Simmons; Nicolas G. Bazan; Walter J. Lukiw

Source: Neurochemical Research, Volume 29, Number 9, September 2004 , pp. 1731-1737(7)

Publisher: Springer

Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea?

Authors: Di Girolamo G.; Sánchez A.J.; De Los Santos A.R.; González C.D.

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 3, 1 March 2004 , pp. 561-570(10)

Publisher: Informa Healthcare

Mécanisme de l'action antinociceptive du paracétamol*

Authors: Jérôme Bonnefont; Jean-Philippe Courade; Abdelkrim Alloui; Alain Eschalier

Source: Drugs, Volume 63, Special Issue 2, 2003 , pp. 1-4(4)

Publisher: Adis International

Mechanisms of action of paracetamol and related analgesics

Authors: Graham G.G.; Scott K.F.

Source: Inflammopharmacology, Volume 11, Numbers 4-6, 2003 , pp. 401-413(13)

Publisher: VSP, an imprint of Brill

COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells

Authors: Shaftel S.S.; Olschowka J.A.; Hurley S.D.; Moore A.H.; O'Banion M.K.

Source: Molecular Brain Research, Volume 119, Number 2, 26 November 2003 , pp. 213-215(3)

Publisher: Elsevier

COX-3: potential drug target of the future

Source: Inpharma, Volume 1, Number 1380, 2003 , pp. 3-3(1)

Publisher: Adis International

COX-3: in the wrong frame in mind

Authors: Dinchuk J.E.; Liu R.Q.; Trzaskos J.M.

Source: Immunology Letters, Volume 86, Number 1, 3 March 2003 , pp. 121-121(1)

Publisher: Elsevier

COX-2 Inhibition, Apoptosis, and Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.

Authors: Moore B.C.; Simmons D.L.

Source: Current Medicinal Chemistry, Volume 7, Number 11, November 2000 , pp. 1131-1144(14)

Publisher: Bentham Science Publishers

COX-3: a new target in inflammatory disease?

Source: Inpharma, Volume 1, Number 1226, 2000 , pp. 3-3(1)

Publisher: Adis International